Tofacitinib (Xeljanz)
Tofacitinib Citrate (Xeljanz) is an oral drug used to treat adults with moderate to severe active rheumatoid arthritis (RA), active psoriatic arthritis, ankylosing spondylitis, moderate to severe ulcerative colitis, and children ages 2 and older with active polyarticular juvenile idiopathic arthritis.
